Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Yasemin Sanli"'
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Fibroblast activation protein (FAP), overexpressed on cancer-associated fibroblasts (CAFs), is a novel target for molecular imaging of various tumors. Recently, the development of several small-molecule FAP inhibitors for radiolabeling with 68Ga has
Externí odkaz:
https://doaj.org/article/f6b7392e8fb940db825892af269b3b9a
Publikováno v:
Biomedicines, Vol 9, Iss 4, p 430 (2021)
The aim of this narrative review is to evaluate the current status of 177Lu-PSMA (prostate specific membrane antigen) therapy for metastatic castration-resistant prostate cancer (mCRPC) in the light of the current literature. We also addressed patien
Externí odkaz:
https://doaj.org/article/3e4b09299b62431796ff24dde6abd19f
Autor:
Kizildag Yirgin, Inci *, Has, Duygu, Arslan, Gozde, Aydin, Esra Cureoglu, Sari, Murat, Onder, Semen, Yasemin, Sanli, Cabioglu, Neslihan, Karanlik, Hasan, Tukenmez, Mustafa, Dursun, Memduh, Muslumanoglu, Mahmut, Ozmen, Vahit
Publikováno v:
In European Journal of Radiology Open 2020 7
Publikováno v:
PET Clinics. 18:201-214
Publikováno v:
Clinical Nuclear Medicine.
Autor:
Duygu Has Simsek, Serkan Kuyumcu, Seyfullah Karadogan, Zeynep Gozde Ozkan, Emine Goknur Isik, Mert Basaran, Mehmet Oner Sanli, Yasemin Sanli
Publikováno v:
Clinical Nuclear Medicine. 47:e521-e528
Autor:
Caner Civan, Duygu Has Simsek, Murat Yilmaz Kiran, Emine Goknur Isik, Zeynep Gozde Ozkan, Yasemin Sanli, Serkan Kuyumcu
Publikováno v:
Physica Medica. 95:83-88
Autor:
Zeynep Gözde Özkan, Duygu Tunçman, Yasemin Sanli, Cuneyt Turkmen, Bayram Demir, Duygu Has Simsek, Bilal Kovan, Emine Goknur Isik, Fikret Büyükkaya
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:17-22
Background: The aim of this study is to clarify the critical organs that limit treatment scheme and also evaluate the validity of currently used critical organ threshold values in neuroendocrine tumor (NET) patients, receiving peptide receptor radion
Publikováno v:
Clinical nuclear medicine. 48(2)
A 60-year-old woman diagnosed with clear cell endometrial carcinoma received neoadjuvant chemotherapy. However, the patient was inoperable and referred to our clinic to evaluate the extent of the disease. The patient underwent 18FDG PET/CT and 68Ga-F
Publikováno v:
Clinical Nuclear Medicine. 48:e223-e224